Artelo Biosciences Reports Third Quarter GAAP EPS of -$3.19
Artelo Biosciences (ARTL) has released its financial results for the third quarter, reporting a GAAP earnings per share (EPS) loss of $3.19. The report highlights the company's current fiscal position as it continues its operations. As of September 30, 2026, the company reported a total cash balance of $4.4 million. These results reflect the ongoing financial standing of the biotechnology firm during this reporting period.